日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Expert consensus on the detection and clinical application of tumor mutational burden

关于肿瘤突变负荷的检测和临床应用的专家共识

Guo, Zhenying; Xu, Chunwei; Zhang, Shirong; Hao, Yue; Hu, Xiaotong; Zhao, Ming; Xiang, Chan; Piao, Yingshi; Sun, Pingli; Xiang, Xueping; Zhao, Jing; Wu, Huanwen; Li, Weixing; Yu, Jinpu; Yuan, Jingping; Wang, Shuangshuang; Wang, Cong; Gu, Yun; Lv, Bingjian; Zhang, Liping; Liu, Yueping; Cui, Xiaobin; Gu, Weizhong; Li, Yining; Wang, Wei; Yang, Wenjun; Long, Weiguo; Xiang, Jingjing; Mou, Hong; Liu, Biao; Ruan, Huajuan; Wang, Yubin; Zhu, Yongjie; Wang, Feng; Wang, Zhonghua; Feng, Xiaomin; Liu, Xing; Li, Peng; Deng, Min; Lian, Bin; Mao, Lili; Wang, Qian; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Zhong, Wenzhao; Wang, Zhijie; Ren, Shengxiang; Fang, Wenfeng; Zhang, Yongchang; Liu, Jingjing; Cai, Xiuyu; Liu, Anwen; Li, Wen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Zhang, Yu; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Shen, Peng; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Guo, Hui; Chu, Qian; Meng, Rui; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Lu, Yuanyuan; Chen, Xiaofeng; Ge, Rui; Dai, Enyong; Han, Yu; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Liu, Xuewen; Yao, Yu; Luo, Peng; Pan, Weiwei; Pang, Fei; Wu, Fan; Gu, Dejian; Wang, Li; Wang, Liping; Zhu, Youcai; Lin, Li; Li, Weiwen; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Ji, Qing; Fang, Yuan; Wei, Qing; Wang, Zhen; Wan, Bin; Lv, Donglai; Li, Xiaofeng; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Li, Bihui; Zhang, Zhang; Wang, Ke; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Zhongwu; Li, Miao; Wang, Guansong; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Wang, Biyun; Si, Lu; Song, Yong; Lu, Yuanzhi; Liu, Aijun; Han, Yuchen

Ensemble learning on serum metabolic fingerprints for early detection of lung adenocarcinoma

基于血清代谢指纹的集成学习用于肺腺癌的早期检测

Cai, Chenlei; Xu, Weijie; Yang, Shuo; Yu, Jia; Wang, Lei; Ren, Shengxiang

Case Report: Complete pathologic response to neoadjuvant immunotherapy-chemotherapy in a patient with RET fusion-positive non-small cell lung cancer

病例报告:RET融合阳性非小细胞肺癌患者接受新辅助免疫治疗-化疗后获得完全病理缓解

Wang, Yan; Zhang, Yan; Cai, Chenlei; Liu, Xinyu; Ren, Shengxiang; Zhou, Songwen

International guidelines on the diagnosis and treatment of NUT carcinoma

关于NUT癌诊断和治疗的国际指南

Zhang, Yu; Zhang, Qi; Hao, Yue; Luo, Jia; Piao, Yingshi; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Brcic, Luka; Liu, Aijun; Yu, Jinpu; Tsutani, Yasuhiro; Zhong, Wenzhao; Fang, Wenfeng; Wang, Zhijie; Ren, Shengxiang; Papavassiliou, Athanasios G; Zhang, Yongchang; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Cangir, Ayten Kayi; Liu, Anwen; Li, Wen; Lococo, Filippo; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Popper, Helmut; Chen, Yu; Yuan, Jingping; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Kairemo, Kalevi; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Leanne, Ashrafian; Li, Xiaoyan; Tang, Chuanhao; Siddique, Hifzur R; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Shelat, Vishal; Guo, Hui; Chu, Qian; Meng, Rui; Ardeshir, Fatemeh; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Kratzke, Robert A; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Calabrese, Fiorella; Xia, Yang; Mariani, Alessandro Wasum; Lu, Yuanyuan; Chen, Xiaofeng; Klein, Mark A; Ge, Rui; Dai, Enyong; Schönthal, Axel H; Han, Yu; Guo, Zhenying; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Chiappetta, Marco; Liu, Xuewen; Salle, Francoise Galateau; Yao, Yu; Szolkowska, Malgorzata; Pan, Weiwei; Pang, Fei; Wu, Fan; Watzka, Stefan B; Wang, Liping; Zhu, Youcai; Lin, Li; Sharma, Aparna; Tu, Jianfei; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Zauderer, Marjorie G; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Dudnik, Elizabeth; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Huang, Jianhui; Feng, Yue; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Baine, Marina K; Sun, Pingli; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Wu, Jing; Yang, Yunyun; Fang, Yuan; Wang, Zhen; Wan, Bin; Lv, Donglai; Chen, Huafei; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Sobeih, Mohamed Emam; Li, Bihui; Lian, Bin; Mao, Lili; Zhang, Zhang; Wang, Ke; Li, Zhongwu; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Miao; Wang, Guansong; Marron, Thomas U; Wang, Jiandong; Popat, Sanjay; Fang, Meiyu; Fang, Yong; Mansilla, Daniel; Li, Yuan; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Mansfield, Aaron S; Wang, Biyun; Si, Lu; Roden, Anja C; Grønberg, Bjørn H; Song, Yong; Shapiro, Geoffrey I; French, Christopher A; Lu, Yuanzhi; Wang, Qian; Xu, Chunwei

Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trial

在接受抗PD-1/L1治疗后出现寡残留病灶的晚期非小细胞肺癌患者中,消融联合免疫疗法与单纯免疫疗法的疗效比较(BOOSTER):一项随机II期试验

Yang, Shuo; Liu, Xinyu; Yu, Jia; Chen, Xiaoxia; Liu, Xiaozhen; Zhao, Sha; Jiang, Tao; Sun, Hui; Yang, Menghang; Wu, Fengying; Li, Aiwu; Wang, Lei; Gao, Guanghui; Xu, Yaping; Chen, Bin; Ren, Shengxiang

Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC.

开发一种抑制非小细胞肺癌中 EGFR 和 B7H3 的双特异性抗体。

Zhi Xinxin, Wang Jiale, Guo Junhong, Luo Libo, Sun Hui, Li Yi, Zhao Zhen, Wang Chenghu, Zhu Lifang, Li Xi, Wang Feng, Li Fei, Yu Kebing, Ren Shengxiang

Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker Analysis

卡瑞利珠单抗(一种抗PD-1单克隆抗体)联合卡铂和白蛋白紫杉醇一线治疗广泛期小细胞肺癌:一项II期临床试验及生物标志物分析

Yu, Jia; Cai, Deyu; Zhao, Sha; Wang, Lei; Zheng, Xinlong; Xiong, Anwen; Wang, Qi; Chen, Bin; Yang, Menghang; Li, Wei; Wang, Yan; Yuan, Jiajia; Zhao, Changhong; Shi, Wei; Zhou, Caicun; Chen, Luonan; Jiang, Tao; Chen, Xiaohui; Ren, Shengxiang

Differential expression of the MYC-Notch axis drives divergent responses to the front-line therapy in central and peripheral extensive-stage small-cell lung cancer

MYC-Notch轴的差异表达导致中枢型和周围型广泛期小细胞肺癌对一线治疗的反应不同

Luo, Libo; Xia, Rui; Mao, Shiqi; Liu, Qian; Du, He; Jiang, Tao; Yang, Shuo; Wang, Yan; Li, Wei; Zhou, Fei; Yu, Jia; Gao, Guanghui; Li, Xuefei; Zhao, Chao; Cheng, Lei; Shi, Jingyun; Chen, Xiaoxia; Zhou, Caicun; Chen, Luonan; Ren, Shengxiang; Wu, Fengying

Updates to the 2024 CSCO advanced non-small cell lung cancer guidelines

2024 年 CSCO 晚期非小细胞肺癌指南更新

Wang, Jiale; Qiu, Tianyu; Ren, Shengxiang

Indoleamine 2,3-dioxygenase-1 expression in non-small-cell lung cancer: analyses of prevalence, clinical correlations and prognostic impact in 2 large patient cohorts

非小细胞肺癌中吲哚胺2,3-双加氧酶-1的表达:两个大型患者队列中患病率、临床相关性和预后影响的分析

Agustoni, Francesco; Yu, Hui; Ellison, Kim; Smith, Derek; Mitchell, Paul; Rivalland, Gareth; Dziadziuszko, Rafal; Gao, Dexiang; Ren, Shengxiang; Rivard, Christopher J; San Millan, Inigo; Corallo, Salvatore; Pedrazzoli, Paolo; Hirsch, Fred R